Table 1 Baseline clinical and echocardiographic characteristics
Characteristics | Remodeling (n = 54) | No remodeling (n = 15) | p value |
|---|---|---|---|
Male | 48 (88.9%) | 14 (93.3%) | 1 |
Age at AVR | 47.5 ± 15 | 45.3 ± 12.7 | 0.593 |
BSA (m2) | 1.9 ± 0.2 | 1.9 ± 0.2 | 0.8 |
Hypertension | 27 (50%) | 5 (33.3%) | 0.394 |
Diabetes mellitus | 2 (3.7%) | 1 (6.7%) | 0.527 |
Coronary artery disease | 7 (13%) | 4 (26.7%) | 0.237 |
Atrial fibrillation | 4 (7.4%) | 2 (13.3%) | 0.604 |
Smoking | 17 (31.5%) | 8 (53.3%) | 0.21 |
NYHA III/IV | 29 (53.7%) | 12 (80%) | 0.124 |
Etiology of AR | 0.057 | ||
Rheumatic | 6 (11.1%) | 3 (20%) | |
Degenerative | 18 (33.3%) | 1 (6.7%) | |
Congenital | 17 (31.5%) | 9 (60%) | |
Other | 13 (24.1%) | 2 (13.3%) | |
Time from diagnosis to surgery (years) surgery (months) | 4.8 ± 6.2 | 15.4 ± 15.8 | < 0.001 |
Echocardiographic parameters | |||
LVEDD (mm) | 70.2 ± 4.6 | 80.6 ± 14.7 | < 0.001 |
LVESD (mm) | 51.7 ± 7.4 | 65.2 ± 18.4 | < 0.001 |
LVEDV (ml) | 230 ± 68.7 | 335.5 ± 149.2 | < 0.001 |
LVESV (ml) | 119.9 ± 51.3 | 203.1 ± 140.8 | 0.001 |
EF (%) | 50.5 ± 10.6 | 37.7 ± 13.1 | 0.007 |
Procedure | 1 | ||
Mechanical | 51 (94.4%) | 15 (100%) | |
Bioprosthesis | 3 (5.6%) | ||